Zoetis Inc.

ZTS

US98978V1035

Pharmaceuticals

Market Closed - Nyse Other stock markets 01:30:02 15/06/2024 am IST			5-day change	1st Jan Change
170.6 ^USD	-0.45%		-3.60%	-13.59%

04/06	Transcript : Zoetis Inc. Presents at The 44th Annual William Blair Growth Stock Conference, Jun-04-2024 02:40 PM
29/05	Transcript : Zoetis Inc. Presents at Stifel Jaws & Paws Conference, May-29-2024 12:05 PM

Zoetis Inc. Announces Retirement of Linda Rhodes as Board of Directors

May 23, 2024 at 04:14 pm IST

Zoetis Inc. announced the retirement of Linda Rhodes as Board of Directors, effective from May 21, 2024, prior to the Company?s 2024 Annual Meeting of Shareholders (the ?Annual Meeting?) in accordance with the Company?s director retirement policy.

Latest news about Zoetis Inc.

Transcript : Zoetis Inc. Presents at The 44th Annual William Blair Growth Stock Conference, Jun-04-2024 02:40 PM	05/06
Transcript : Zoetis Inc. Presents at Stifel Jaws & Paws Conference, May-29-2024 12:05 PM	29/05
Declaration of Voting Results by Zoetis Inc	23/05	CI
Zoetis Inc. Announces Retirement of Linda Rhodes as Board of Directors	23/05	CI
Zoetis Keeps Quarterly Dividend at $0.432 a Share, Payable Sept. 4 to Shareholders of Record July 18	23/05	MT
Zoetis Inc. Declares Dividend for the Third Quarter of 2024, Payable on September 4, 2024	23/05	CI
The latest transactions by star managers	21/05
HSBC Adjusts Price Target on Zoetis to $225 From $230	08/05	MT
BNP Paribas Exane Adjusts Price Target on Zoetis to $232 From $237	06/05	MT
The market resurrects the Fed Put	06/05
Goldman Sachs Adjusts Price Target on Zoetis to $196 From $223	06/05	MT
Redburn Atlantic Adjusts Price Target on Zoetis to $220 From $230, Keeps Buy Rating	03/05	MT
Global markets live: Etsy, Qualcomm, Carvana, Rio Tinto, Apple...	02/05
Transcript : Zoetis Inc., Q1 2024 Earnings Call, May 02, 2024	02/05
Zoetis' Q1 Adjusted Earnings, Revenue Rise; 2024 Outlook Lowered	02/05	MT
(ZTS) ZOETIS Expects Fiscal Year 2024 Revenue Range $9.05B - $9.2B	02/05	MT
(ZTS) ZOETIS Sees Fiscal Year 2024 EPS Range $5.71 - $5.81	02/05	MT
Earnings Flash (ZTS) ZOETIS Posts Q1 Revenue $2.19B	02/05	MT
Earnings Flash (ZTS) ZOETIS Posts Q1 EPS $1.38	02/05	MT
Zoetis Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	02/05	CI
Zoetis Inc. Revises Earnings Guidance for the Year 2024	02/05	CI
Corn Futures Rise on Potential Planting Delay -- Daily Grain Highlights	02/05	DJ
Stifel Adjusts Price Target on Zoetis to $180 From $195	30/04	MT
Zoetis to Sell Medicated-Feed-Additive Portfolio to Phibro for $350 Million	29/04	DJ
Zoetis to Sell Medicated Feed Additives Business to Phibro Animal Health for $350 Million	29/04	MT

Chart Zoetis Inc.

Duration

Period

More charts

Company Profile

Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows: - pets (64.4%): cats and dogs (94.9% of net sales) and horses (5.1%); - livestock (34.5%): cattle (51.6% of sales), swine (20.2%), poultry (17.1%), fish (7.6%) and other (3.5%); - other (1.1%). Net sales break down by family of products into parasiticides (23%), vaccines (21.3%), dermatological products (16.4%), anti-infectives (13.4%), medical food additives (4.5%), diagnostic products (4.4%) and other (17%). At the end of 2022, the group has 29 production sites worldwide. The United States accounts for 53.4% of net sales.

Sector

Pharmaceuticals

Calendar

01/08/2024 - Q2 2024 Earnings Release (Projected)

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for Zoetis Inc.

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

170.6 USD

Average target price

210.2 USD

Spread / Average Target

+23.22%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Veterinary Drugs

	1st Jan change	Capi.
ZOETIS INC.	-13.59%	77.82B
ELANCO ANIMAL HEALTH INCORPORATED	+21.01%	8.91B
VIRBAC	-5.56%	3.04B
VIMIAN GROUP AB	+13.68%	1.67B
VETOQUINOL SA	-5.27%	1.23B
JINYU BIO-TECHNOLOGY CO., LTD.	-29.81%	1.16B
CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD.	-31.11%	1.15B
WUHAN KEQIAN BIOLOGY CO.,LTD	-22.47%	1.01B
TIANJIN RINGPU BIO-TECHNOLOGY CO.,LTD.	-12.32%	916M
SWEDENCARE AB	-3.22%	889M

Veterinary Drugs

Zoetis Inc.

Equities

ZTS

US98978V1035

Pharmaceuticals

Zoetis Inc. Announces Retirement of Linda Rhodes as Board of Directors

EPS Revisions